News & Media: All

Feb 4, 2016

Precision's Lakdawalla on the BBC: 'You can't just ban Twinkies'

Precision's Darius Lakdawalla was recently interviewed for the BBC's Business Daily program, discussing the trend to ban large size sodas and other recent anti-junk food measures.

To play the interview, please click here.

Jan 19, 2016

Philipson in Forbes: Republicans and Democrats Both Wrong on Obamacare

in Tomas Philipson's latest Forbes.com Op-Ed, he illustrates how both Democrats and Republicans are both misguided in their view of the historical impact of Obamacare.

To read the editorial, please click here.

Jan 14, 2016

Precision's Renick in AMCP Q & A

Precision for Value’s President Dan Renick recently participated in a Q & A with the Academy of Managed Care Pharmacy, appearing in their newsletter. To read the complete article, please click here.

Dec 22, 2015

TPG Invests in Precision for Medicine

Leader in healthcare investing acquires stake in growing pharmaceutical services company.

Fort Worth, Texas, San Francisco and Bethesda, MD — December 22, 2015 — TPG Growth, the middle market and growth equity investment platform of TPG, a leading global private investment firm with appro ...

Dec 18, 2015

Goldman In Modern Healthcare: Drop Medicaid 'Best Price' Drug Rules

Dana Goldman's latest editorial for Modern Healthcare suggests dropping the "best price" drug rules in favor of value-based strategies.

To read the complete editorial, please click here.

Dec 7, 2015

Philipson in Forbes: "Overdosing on Protection"

Tomas Philipson's latest Forbes.com Op-Ed examines the FDA and the current product liability system.

To read the complete editorial, please click here.

Nov 24, 2015

Precision's Jena to Participate in Upcoming AEI Forum

Precision's Principal Consultant Anupam Jena has been invited by the AEI to participate in a upcoming forum: "Rethinking the storyline for defensive medicine and medical liability: Causes, effects, and remedies."  The forum will be held on December 2nd, 2015 from 3:30-5:00pm ET at the AEI in Was ...

Nov 23, 2015

Precision's Karen Becker Quoted in Roll Call

Precision for Medicine’s Karen Becker has been quoted in the latest edition of Roll Call, as Congress considers regulation of Lab-Developed Tests.

Here is the complete article:

Roll Call

November 20, 2015

Congress Considers Regulation of Lab-Developed Tests

By Andrew Siddons

As the Food ...

Nov 17, 2015

Philipson Quoted in Bloomberg BNA's Health Care Policy Report

Precision's Tomas Philipson was quoted in the just-released Bloomberg BNA Health Care Policy Report. Also look for Precision Scientific Advisor Seth Seabury's contributions to the report.

To read the complete report, please click the following link: Study Says More Doctor Spending Linked to Few ...

Nov 4, 2015

Precision for Value Acquires Redwood Outcomes

Extends Leadership and Global Reach in Health Economics and Outcomes Research

Gladstone, N.J. and Vancouver, B.C., November 4, 2015 – Precision for Value (Precision) today announced that it has acquired Redwood Outcomes, a leading international health economics and outcomes research (HEOR) ...

Nov 3, 2015

Philipson in Forbes: Myths and Facts About Specialty Drugs

Along with co-authors Dana Goldman and Anupam Jena, Tomas Philipson's latest Forbes.com op-ed examines some common myths about specialty drugs.

To read the complete article, please click here.

Oct 27, 2015

Precision's Tomas Philipson Advocates for Advancement of Drug Development In New York Times

Precision Health Economics founding partner Tomas Philipson has joined a prestigious group advocating for the advancement of drug development. In association with the Manhattan Institute, Dr. Philipson's endorsement has been included in a full-page ad that recently ran in the New York Times.

T ...

Oct 8, 2015

Chandra and Goldman in Harvard Business Review

Precision's Chief Scientific Officer Amitabh Chandra and PHE founding partner Dana Goldman address health care's Short-Termism problem in their latest article for the Harvard Business Review.

To view the complete article, please click here.

Oct 7, 2015

Philipson in Forbes: Do We Want Centralized or Decentralized Medicine?

In Tomas Philipson's latest Forbes.com Op-Ed, he addresses "step therapy" and centralized vs. decentralized medicine.

To read the complete commentary, please click here.

Oct, 2015

Goldman & Lakdawalla in Health Affairs Blog: "Moving Beyond Pay-Per-Dose"

Precision Health Economics founding partners Dana Goldman and Darius Lakdawalla address the need to evolve beyond price-per-dose in the pharmaceutical industry in their latest Health Affairs blog post.

To read the complete article, please click here.

Sep 30, 2015

Precision's Goldman and Lakdawalla Participate in "Future of Specialty Drugs" DC Conference

Precision Health Economics founding partners Dana Goldman and Darius Lakdawalla participated in a conference on Thursday, Oct. 1st, focusing on the future of specialty drugs. The conference, co-sponsored by USC's Schaeffer Center, The Hill, and Amgen took place at The Newseum in Washington, DC. ...

Sep 29, 2015

Philipson Addresses Innovation in Celgene Newsroom Article

Precision Health Economics founding partner Tomas Philipson was quoted on the topic of medical innovation in an article appearing in the Celgene Newsroom. To read the complete article, please click here.

Sep 24, 2015

Precision's Lakdawalla Weighs In On Drug Pricing Controls in New York Times

Precision Health Economics founding partner Darius Lakdawalla weighs in on drug pricing controls in this week's New York Times Opinion feature, "Room for Debate."

To read the complete article, please click here.

Sep 4, 2015

Tomas Philipson In Forbes: "World Returns In Health Care Will Drive How Long You Live, But Your Country Will Stand In Your Way"

Tomas Philipson's latest Forbes.com Op-Ed examines how international linkages between health care economies will affect how long you and your kids will live.

To read the complete commentary, please click here.

Aug 26, 2015

Precision Digital Trends Survey: What Payers Want From Pharma Can Vary

New York, August 26, 2015 – Precision Advisors (www.precisionadvisors.com), a Precision for Value company, today announced additional findings from its 2015 Digital Trends Study of managed care executives on the types of information Managed Care Organizations (MCOs) requested and received fro ...

Aug 19, 2015

Precision's MacEwan Participates in NEHI "On Call" Series

The Network for Excellence in Health Innovation (NEHI) held a special forum on August 19th, focusing on better use of medicines in diabetes, featuring the recent study and ADA presentation by Precision's Joanna MacEwan.

Dr. MacEwan discussed her recent work and fielded questions from the NEHI ...

Aug 10, 2015

Philipson in Forbes: "Dying to Live"

Tomas Philipson's latest Forbes.com Op-Ed examines end of life care, and why health care is so valuable in the face of death.

To read the complete article, please click here.